HealthCare Global Enterprises (HCG) has acquired oncology hospital labs and clinical trials business from Strand Lifesciences as well as simultaneous the company divested its 38.5% stake (on paid-up capital basis and 34.5% on fully diluted basis) in Strand to Reliance Industries group company.
HCG received consideration of around Rs 157 crore for sale of its ownership in Strand and acquired labs and clinical research business through a Business Transfer Agreement (BTA) from Strand for a consideration of Rs 81 crore with a set-off of Rs 7 crore towards receivables. The transactions resulted in net cash inflow of Rs 83 crore for HCG in addition to the take-over of the labs and clinical research business.
The company is Bangalore based provider of speciality healthcare in India focused on cancer and fertility. It operates the largest cancer care network in India in terms of the total number of private cancer treatment centres licensed. It also operates fertility centres under the ‘Milann’ brand.
Company Name | CMP |
---|---|
Apollo Hospital Ent. | 6694.40 |
Max Healthcare Inst | 1039.35 |
Narayana Hrudayalay | 1287.85 |
Aster DM Healthcare | 489.85 |
Global Health | 1023.35 |
View more.. |